Leif Lindström

3.9k total citations
63 papers, 3.1k citations indexed

About

Leif Lindström is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Leif Lindström has authored 63 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Psychiatry and Mental health, 15 papers in Cellular and Molecular Neuroscience and 10 papers in Cognitive Neuroscience. Recurrent topics in Leif Lindström's work include Schizophrenia research and treatment (27 papers), Tryptophan and brain disorders (8 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Leif Lindström is often cited by papers focused on Schizophrenia research and treatment (27 papers), Tryptophan and brain disorders (8 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Leif Lindström collaborates with scholars based in Sweden, Denmark and Japan. Leif Lindström's co-authors include Conny Nordin, Göran Engberg, Jerzy Leppert, Lars Oreland, Kent W. Nilsson, Rickard L. Sjöberg, Sophie Erhardt, Kaj Blennow, Elisabeth Skogh and Ing‐Marie Wieselgren and has published in prestigious journals such as Biological Psychiatry, Journal of Abnormal Psychology and The British Journal of Psychiatry.

In The Last Decade

Leif Lindström

60 papers receiving 3.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Leif Lindström 1.3k 862 805 526 522 63 3.1k
Felice Iasevoli 1.2k 1.0× 1.3k 1.5× 731 0.9× 757 1.4× 985 1.9× 144 4.0k
Teruhiko Higuchi 945 0.8× 525 0.6× 755 0.9× 398 0.8× 550 1.1× 126 3.4k
Tetsuro Ohmori 1.3k 1.1× 1.3k 1.5× 774 1.0× 495 0.9× 1.2k 2.2× 180 4.4k
Galila Agam 503 0.4× 667 0.8× 682 0.8× 219 0.4× 891 1.7× 68 3.2k
D. Eccleston 949 0.8× 1.4k 1.6× 575 0.7× 296 0.6× 661 1.3× 94 3.5k
Paul J. Orsulak 1.1k 0.9× 789 0.9× 530 0.7× 546 1.0× 450 0.9× 95 3.5k
Paulo Belmonte‐de‐Abreu 1.7k 1.4× 655 0.8× 946 1.2× 515 1.0× 669 1.3× 120 3.6k
Ranan Rimón 1.1k 0.8× 917 1.1× 579 0.7× 721 1.4× 462 0.9× 130 3.3k
Carlo Altamura 778 0.6× 334 0.4× 756 0.9× 614 1.2× 302 0.6× 56 2.8k
Robert H. Gerner 1.1k 0.9× 800 0.9× 479 0.6× 660 1.3× 343 0.7× 66 3.0k

Countries citing papers authored by Leif Lindström

Since Specialization
Citations

This map shows the geographic impact of Leif Lindström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leif Lindström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leif Lindström more than expected).

Fields of papers citing papers by Leif Lindström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leif Lindström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leif Lindström. The network helps show where Leif Lindström may publish in the future.

Co-authorship network of co-authors of Leif Lindström

This figure shows the co-authorship network connecting the top 25 collaborators of Leif Lindström. A scholar is included among the top collaborators of Leif Lindström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leif Lindström. Leif Lindström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nilsson, Björn M., et al.. (2017). Tachycardia in patients treated with clozapine versus antipsychotic long-acting injections. International Clinical Psychopharmacology. 32(4). 219–224. 21 indexed citations
2.
Malm, Ulf, et al.. (2010). The self-assessment Global Quality of Life scale: Reliability and construct validity. International Journal of Psychiatry in Clinical Practice. 14(4). 287–297. 12 indexed citations
3.
Bodén, Robert, Arvo Haenni, Leif Lindström, & Johan Sundström. (2009). Biochemical risk factors for development of obesity in first-episode schizophrenia. Schizophrenia Research. 115(2-3). 141–145. 12 indexed citations
4.
Bodén, Robert, Johan Sundström, Eva Lindström, Ing‐Marie Wieselgren, & Leif Lindström. (2009). Five-year outcome of first-episode psychosis before and after the implementation of a modified assertive community treatment programme. Social Psychiatry and Psychiatric Epidemiology. 45(6). 665–674. 21 indexed citations
5.
Wallsten, Tuula, Lars Kjellin, & Leif Lindström. (2006). Short-term outcome of inpatient psychiatric care—impact of coercion and treatment characteristics. Social Psychiatry and Psychiatric Epidemiology. 41(12). 975–980. 37 indexed citations
6.
Atlas, Ann, Magnus Gisslén, Conny Nordin, Leif Lindström, & Lilly Schwieler. (2006). Acute psychotic symptoms in HIV-1 infected patients are associated with increased levels of kynurenic acid in cerebrospinal fluid. Brain Behavior and Immunity. 21(1). 86–91. 47 indexed citations
7.
Nilsson, Kent W., Mattias Damberg, John Öhrvik, et al.. (2006). Genes encoding for AP-2β and the Serotonin Transporter are associated with the Personality Character Spiritual Acceptance. Neuroscience Letters. 411(3). 233–237. 36 indexed citations
8.
Sjöberg, Rickard L., Kent W. Nilsson, Hanna‐Linn Wargelius, et al.. (2006). Adolescent girls and criminal activity: Role of MAOA‐LPR genotype and psychosocial factors. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 144B(2). 159–164. 114 indexed citations
9.
Hashimoto, Kenji, Göran Engberg, Eiji Shimizu, et al.. (2005). Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients. BMC Psychiatry. 5(1). 6–6. 90 indexed citations
10.
Hashimoto, Kenji, Göran Engberg, Eiji Shimizu, et al.. (2005). Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 29(5). 767–769. 210 indexed citations
11.
Гефверт, О., Leif Lindström, Nicholas Waters, et al.. (2003). Different corticostriatal patterns of L‐DOPA utilization in patients with untreated schizophrenia and patients treated with classical antipsychotics or clozapine. Scandinavian Journal of Psychology. 44(3). 289–292. 20 indexed citations
12.
Lööf, Lars, Jerzy Leppert, Leif Bergkvist, et al.. (2002). [Clinical research and continuing education on county hospital level. Experiences with cooperation between health care and academies].. PubMed. 99(46). 4624–7. 1 indexed citations
13.
Гефверт, О., et al.. (2001). D2 and 5HT2A receptor occupancy of different doses of quetiapine in schizophrenia: a PET study. European Neuropsychopharmacology. 11(2). 105–110. 93 indexed citations
14.
Wieselgren, Ing‐Marie & Leif Lindström. (1998). CSF levels of HVA and 5-HIAA in drug-free schizophrenic patients and healthy controls: a prospective study focused on their predictive value for outcome in schizophrenia. Psychiatry Research. 81(2). 101–110. 35 indexed citations
15.
Hultman, Christina M., Arne Öhman, Sven Cnattingius, Ing‐Marie Wieselgren, & Leif Lindström. (1997). Prenatal and neonatal risk factors for schizophrenia. The British Journal of Psychiatry. 170(2). 128–133. 102 indexed citations
16.
Lindström, Leif, Per Hartvig, Hans Ågren, et al.. (1996). Serotonin-2 and dopamine-1 binding components of clozapine in frontal cortex and striatum in the human brain visualized by positron emission tomography. Psychiatry Research Neuroimaging. 67(1). 1–10. 7 indexed citations
17.
Nordin, Conny, Leif Lindström, & Ing‐Marie Wieselgren. (1996). Acid monoamine metabolites in the CSF of healthy controls punctured without preceding strict bedrest: A retrospective study. Journal of Psychiatric Research. 30(2). 127–133. 15 indexed citations
18.
Lindström, Leif, Ing‐Marie Wieselgren, I. Klockhoff, & Alf Svedberg. (1990). Relationship between abnormal brainstem auditory-evoked potentials and subnormal CSF levels of HVA and 5-HIAA in first-episode schizophrenic patients. Biological Psychiatry. 28(5). 435–442. 23 indexed citations
19.
Öhlund, Lennart S., et al.. (1990). Season of birth and electrodermal unresponsiveness in male schizophrenics. Biological Psychiatry. 27(3). 328–340. 16 indexed citations
20.
Lindström, Leif, et al.. (1988). Reduced CSF neurotensin concentration in drug-free schizophrenic patients. Schizophrenia Research. 1(1). 55–59. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Felice Iasevoli Breakdown of academic impact, for papers by Teruhiko Higuchi Breakdown of academic impact, for papers by Tetsuro Ohmori Breakdown of academic impact, for papers by Galila Agam Breakdown of academic impact, for papers by D. Eccleston Breakdown of academic impact, for papers by Paul J. Orsulak Breakdown of academic impact, for papers by Paulo Belmonte‐de‐Abreu Breakdown of academic impact, for papers by Ranan Rimón Breakdown of academic impact, for papers by Carlo Altamura Breakdown of academic impact, for papers by Robert H. Gerner
Rankless by CCL
2026